BREAKING NEWS BREAKING

• Opposition Leader Mahmood Achakzai Agrees to Talks at Prime Minister’s House • China Emerges as Key Supplier of Water Technology to Global Markets • France Implements Fast-Track Justice Amid Ongoing Riots and Violence • Tech Giants Boost Funding for Data Centers Amid Environmental Concerns • Venezuela’s Morichales Guardian Champions Water and Carbon Conservation • Cybersecurity Alert: New AI Vulnerabilities Threaten Government Websites • Germany Faces Increased Espionage Threats Following Arrest of Suspected Spy • Developers Race to Patch Critical Cybersecurity Flaws in PHP Systems • Ali Zafar Claims Government’s Decision to Impose Emergency Was Inevitable • Three Militants Killed in Failed Attack on Construction Camp in Gwadar • Islamabad Sees Surge in Graveyard Land Applications, Says Talal Chaudhry • Ron Duguay, Former New York Rangers Forward, Passes Away After Cancer Fight • Opposition Leader Mahmood Achakzai Agrees to Talks at Prime Minister’s House • China Emerges as Key Supplier of Water Technology to Global Markets • France Implements Fast-Track Justice Amid Ongoing Riots and Violence • Tech Giants Boost Funding for Data Centers Amid Environmental Concerns • Venezuela’s Morichales Guardian Champions Water and Carbon Conservation • Cybersecurity Alert: New AI Vulnerabilities Threaten Government Websites • Germany Faces Increased Espionage Threats Following Arrest of Suspected Spy • Developers Race to Patch Critical Cybersecurity Flaws in PHP Systems • Ali Zafar Claims Government’s Decision to Impose Emergency Was Inevitable • Three Militants Killed in Failed Attack on Construction Camp in Gwadar • Islamabad Sees Surge in Graveyard Land Applications, Says Talal Chaudhry • Ron Duguay, Former New York Rangers Forward, Passes Away After Cancer Fight

Scientists Administer AI-Designed Viruses in Groundbreaking Human Trial

October 22, 2026 • 1 hour ago •

ISLAMABAD: In a landmark development, scientists have successfully administered artificial intelligence-designed viruses to a human patient, marking a significant milestone in experimental medical treatments. This unprecedented trial aims to explore the potential of AI in creating targeted therapies for various diseases.

The treatment was conducted by a team of researchers at a leading medical institution, who utilized advanced algorithms to design viruses that can selectively target and eliminate diseased cells. According to Dr. Ayesha Khan, the lead researcher, “This innovative approach could revolutionize how we treat illnesses, offering more precise and effective options for patients.”

The implications of this breakthrough are profound, potentially paving the way for new therapies that could address conditions currently deemed difficult to treat. As healthcare systems worldwide grapple with rising costs and complex diseases, AI-designed treatments may offer a more efficient and personalized approach to patient care.

Looking ahead, the research team plans to monitor the patient closely for any adverse reactions and assess the effectiveness of the treatment over the coming months. Further studies are expected to expand on this initial trial, with hopes of developing a comprehensive treatment protocol that could be made available to a broader patient population.

📲 Install App